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Jenis Kelamin Pasien 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Laki - laki 32 55.2 55.2 55.2 
Perempuan 26 44.8 44.8 100.0 





Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid < 31 tahun 8 13.8 13.8 13.8 
31 - 40 tahun 8 13.8 13.8 27.6 
41 - 50 tahun 8 13.8 13.8 41.4 
51 - 60 tahun 15 25.9 25.9 67.2 
> 60 tahun 19 32.8 32.8 100.0 






   Statistic Std. Error 
Kreatinin 1 Mean 1.9836 .33878 
95% Confidence Interval for 
Mean 
Lower Bound 1.3052  
Upper Bound 2.6620  
5% Trimmed Mean 1.5467  
Median 1.2550  
Variance 6.657  
Std. Deviation 2.58010  
51 
 
Minimum .38  
Maximum 16.65  
Range 16.27  
Interquartile Range 1.34  
Skewness 4.169 .314 
Kurtosis 20.283 .618 
Kreatinin 2 Mean 2.1252 .31569 
95% Confidence Interval for 
Mean 
Lower Bound 1.4930  
Upper Bound 2.7573  
5% Trimmed Mean 1.7540  
Median 1.3300  
Variance 5.780  
Std. Deviation 2.40425  
Minimum .12  
Maximum 13.33  
Range 13.21  
Interquartile Range 1.53  
Skewness 3.177 .314 
Kurtosis 11.538 .618 
Kreatinin 3 Mean 2.7338 .37335 
95% Confidence Interval for 
Mean 
Lower Bound 1.9862  
Upper Bound 3.4814  
5% Trimmed Mean 2.3378  
Median 1.8150  
Variance 8.085  
Std. Deviation 2.84333  
Minimum .20  
Maximum 16.02  
Range 15.82  
Interquartile Range 2.44  
Skewness 2.865 .314 
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Kurtosis 10.193 .618 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
Kreatinin 1 .267 58 .000 .525 58 .000 
Kreatinin 2 .252 58 .000 .625 58 .000 
Kreatinin 3 .205 58 .000 .694 58 .000 
a. Lilliefors Significance Correction    
 
Descriptives 
   Statistic Std. Error 
Lab1trans Mean .1344 .04431 
95% Confidence Interval for 
Mean 
Lower Bound .0457  
Upper Bound .2231  
5% Trimmed Mean .1139  
Median .0986  
Variance .114  
Std. Deviation .33746  
Minimum -.42  
Maximum 1.22  
Range 1.64  
Interquartile Range .43  
Skewness .903 .314 
Kurtosis 1.254 .618 
Lab2trans Mean .1637 .04807 
95% Confidence Interval for 
Mean 
Lower Bound .0675  
Upper Bound .2600  
5% Trimmed Mean .1599  
Median .1239  
Variance .134  
Std. Deviation .36611  
53 
 
Minimum -.92  
Maximum 1.12  
Range 2.05  
Interquartile Range .46  
Skewness .164 .314 
Kurtosis 1.165 .618 
Lab3trans Mean .2748 .04933 
95% Confidence Interval for 
Mean 
Lower Bound .1761  
Upper Bound .3736  
5% Trimmed Mean .2760  
Median .2588  
Variance .141  
Std. Deviation .37567  
Minimum -.70  
Maximum 1.20  
Range 1.90  
Interquartile Range .52  
Skewness .036 .314 
Kurtosis .337 .618 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
 Statistic df Sig. Statistic df Sig. 
Lab1trans .093 58 .200* .953 58 .025 
Lab2trans .089 58 .200* .976 58 .307 
Lab3trans .056 58 .200* .991 58 .937 
a. Lilliefors Significance Correction    








General Linear Model 
Multivariate Testsb 
Effect Value F Hypothesis df Error df Sig. 
Partial Eta 
Squared 
Time Pillai's Trace .248 9.245a 2.000 56.000 .000 .248 
Wilks' Lambda .752 9.245a 2.000 56.000 .000 .248 
Hotelling's Trace .330 9.245a 2.000 56.000 .000 .248 
Roy's Largest Root .330 9.245a 2.000 56.000 .000 .248 
a. Exact statistic       
b. Design: Intercept  
 Within Subjects Design: Time 
     
 
Mauchly's Test of Sphericityb 
Measure:MEASURE_1      
Within 
Subject
s Effect Mauchly's W 
Approx. Chi-
Square df Sig. 
Epsilona 
Greenhouse-
Geisser Huynh-Feldt Lower-bound 
Time .773 14.454 2 .001 .815 .835 .500 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent 
variables is proportional to an identity matrix. 
a. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests 
are displayed in the Tests of Within-Subjects Effects table. 
b. Design: Intercept  
 Within Subjects Design: Time 












Tests of Within-Subjects Effects 
Measure:MEASURE_1       
Source 
Type III Sum 
of Squares df 
Mean 
Square F Sig. 
Partial Eta 
Squared 
Time Sphericity Assumed .637 2 .318 13.880 .000 .196 
Greenhouse-Geisser .637 1.629 .391 13.880 .000 .196 
Huynh-Feldt .637 1.671 .381 13.880 .000 .196 
Lower-bound .637 1.000 .637 13.880 .000 .196 
Error(Time) Sphericity Assumed 2.614 114 .023    
Greenhouse-Geisser 2.614 92.873 .028    
Huynh-Feldt 2.614 95.224 .027    












(I-J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
1 2 -.029 .021 .497 -.081 .022 
3 -.140* .033 .000 -.221 -.059 
2 1 .029 .021 .497 -.022 .081 
3 -.111* .029 .001 -.183 -.039 
3 1 .140* .033 .000 .059 .221 
2 .111* .029 .001 .039 .183 
Based on estimated marginal means    
a. Adjustment for multiple comparisons: Bonferroni.  
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Data Rekam Medik 
NO. CM Jenis Kelamin Pem. 1 Pem. 2 Pem. 3 
C292190 Laki - laki 1.54 1.74 3.51 
C286291 Laki - laki 1.71 1.58 2.1 
C285131 Perempuan 0.5 1 1.06 
C272181 Laki - laki 0.98 1.33 1.6 
C320638 Laki - laki 16.65 13.33 16.02 
C299378 Perempuan 0.61 0.4 0.83 
C318918 Perempuan 1.08 1.76 1.84 
C180328 Laki - laki 2.38 2.8 3.5 
C294388 Laki - laki 2.37 2.51 5 
B424608 Laki - laki 3.13 4.97 6.43 
C318408 Perempuan 0.76 1.33 1.9 
C289976 Laki - laki 0.87 0.96 1.3 
C158795 Laki - laki 1.75 2.26 1.7 
C296795 Laki - laki 1.23 1.86 6.36 
C290355 Laki - laki 1.3 1.41 1.39 
C115315 Perempuan 0.5 0.5 1 
C272575 Laki - laki 1.9 1.11 1.05 
C243965 Perempuan 1 1.79 2.2 
C306937 Laki - laki 1.7 1.8 1.4 
C324127 Perempuan 0.97 1.3 0.96 
C324927 Laki - laki 2.39 2.45 3 
C320377 Laki - laki 1.28 1.22 1.43 
C323706 Laki - laki 0.92 1.11 1.59 
C320965 Laki - laki 0.64 1.84 1.1 
C313345 Perempuan 0.54 0.74 0.84 
C322435 Laki - laki 1.38 0.76 0.7 
C298578 Perempuan 2.21 2.76 2.7 
C295158 Laki - laki 10.99 11.75 13.28 
B381387 Perempuan 0.68 1.15 1.23 
C295857 Perempuan 2.11 2.02 2.38 
C050802 Laki - laki 3.3 2.7 2.1 
C291522 Perempuan 1.17 0.72 0.67 
C307703 Perempuan 1.57 0.8 2.04 
C282263 Laki - laki 3.87 3.02 2.92 
C270573 Perempuan 0.63 0.7 1.14 
B216894 Laki - laki 2.9 2.7 3.54 
C295964 Perempuan 1.05 1.1 1.37 
C320141 Perempuan 1.34 1.39 1.37 
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C320941 Perempuan 0.82 0.87 0.64 
C148841 Perempuan 0.38 0.12 0.27 
C326011 Laki - laki 0.75 0.72 0.2 
C321580 Laki - laki 1.76 2.19 3.24 
C319000 Perempuan 0.38 0.32 0.48 
C304242 Perempuan 0.5 0.54 5.9 
C328502 Perempuan 4.91 5.21 4.38 
C314833 Perempuan 0.72 0.7 0.96 
C306603 Laki - laki 1.9 2.18 2.3 
C178753 Laki - laki 6.08 6.47 7.03 
C211743 Laki - laki 1.02 0.81 1.18 
C230196 Perempuan 2.95 5.93 4.84 
C322206 Laki - laki 1.23 2.3 3.06 
C258918 Laki - laki 1.39 1.22 3.9 
C300224 Perempuan 3.8 4.45 5.7 
C322374 Laki - laki 0.97 0.71 0.85 
C300581 Perempuan 0.81 0.99 1.79 
C322007 Laki - laki 1.34 1.31 4.53 
C295385 Laki - laki 0.95 1.05 2.16 
C299614 Perempuan 0.49 0.5 0.6 
 
